PBM Kickback Prohibition Act
To amend section 408 of the Employee Retirement Income Security Act of 1974 to prohibit kickbacks to pharmacy benefit managers.
The PBM Kickback Prohibition Act aims to stop illegal payments, known as kickbacks, between pharmacy benefit managers (PBMs) and pharmaceutical companies. These kickbacks can increase the cost of prescription drugs for consumers. The bill amends the Employee Retirement Income Security Act of 1974 to make these payments illegal and enforce stricter penalties.
This bill affects anyone who pays for prescription drugs, including employees, retirees, and people with health insurance. By prohibiting kickbacks, the bill could lead to lower drug prices, benefiting everyone who pays for medications. This includes millions of Americans who depend on prescription drugs for their health.
HB7895 was introduced on March 12, 2026, and was referred to the House Committee on Education and Workforce. On May 21, 2026, the committee reported the bill with amendments. The House then placed the bill on the Union Calendar. The bill is currently under consideration in the House.
